Detalhe da pesquisa
1.
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506.
Mol Cancer Ther
; 20(12): 2372-2383, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625504
2.
Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials.
Clin Transl Radiat Oncol
; 15: 62-69, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30734002
3.
Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity.
Radiother Oncol
; 141: 247-255, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431383
4.
Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cells.
Oncotarget
; 9(42): 26800-26816, 2018 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29928486
5.
New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs.
Eur J Med Chem
; 127: 691-702, 2017 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27823879
6.
Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis.
Front Oncol
; 6: 69, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27066453
7.
The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.
PLoS One
; 11(8): e0161040, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27513947
8.
Synthesis and in Vivo Biological Evaluation of (68)Ga-Labeled Carbonic Anhydrase IX Targeting Small Molecules for Positron Emission Tomography.
J Med Chem
; 59(13): 6431-43, 2016 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27322137
9.
New ways to image and target tumour hypoxia and its molecular responses.
Radiother Oncol
; 116(3): 352-7, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26324018